The last couple of months saw a pair of regulatory clearances from mobile ECG maker AliveCor surface on the FDA’s 510(k) premarket notification database — the first in March for something called KardiaAI, and the latter a dual-update for the company’s existing KardiaMobile and KardiaStation platforms for consumer and point-of-care use.
With AliveCor keeping mum at the time, MobiHealthNews...
Smartphone-connected ECG maker AliveCor has officially named an interim CEO, shortly after securing $20 million in debt funding from Oxford Finance. Ira Bahr, the new interim CEO and former chief commercial officer, told MobiHealthNews that the company is gearing up for a big year in 2019.
“I think we’re going to do more in the next six months than we have in the last six years,” he said. “That...
AliveCor has launched (and received FDA clearance for) a new ECG sensor built into an Apple Watch strap, as well as an Apple Watch app on which users can see their ECG in near real-time.
The strap, called KardiaBand, is an upgraded version of a product that launched in Europe last year. But in addition to the band, AliveCor is launching SmartRhythm, a software that continuously measures heart...
AliveCor, makers of the Kardia Mobile smartphone-connected ECG, announced the results of several major studies of the technology, including one that was published online today in Circulation, the journal of the American Heart Association. The studies show the effectiveness of the technology in discovering atrial fibrillation that might otherwise have gone undetected, as well as its ease of use.
"...
Smartphone ECG company AliveCor announced $30 million in new funding today, led by the Mayo Clinic and Omron Healthcare. At the same time, the company launched Kardia Pro, its first provider-facing offering, which uses AI to give cardiologists only the relevant information about their patient's ECGs.
"When we’ve talked to doctors in the past who’ve recommended our device .. and we said 'What do...
AliveCor which makes an mobile electrocardiogram device, will integrate data from Omron Healthcare's Bluetooth blood pressure devices into its ECG Kardia Mobile application. The clinically validated, direct-to-consumer app ECG and blood pressure monitor will patients with a more complete view of their heart health, improve proactive monitoring and create a new standard of care for people at risk...
A new study from the University of Buffalo showed that not only did AliveCor's smartphone-connected heart monitor detect as many arrythmias as a traditional 14-day cardiac event monitor, but patients were also considerably more adherent to the smartphone-connected device.
"The point of the study was to determine whether any smartphone app could be good enough to replace what we normally use now,...
AliveCor is continuing to build up the clinical evidence for the efficacy of its smartphone-connected Kardia ECG devices. According to a new posting on ClinicalTrials.gov, AliveCor is gearing up to launch a 300-patient randomized trial at Columbia University to test the effect of technology-enabled remote monitoring on atrial fibrillation.
"Atrial fibrillation (AF), a condition where the top...
This morning, San Francisco-based AliveCor rebranded its AliveCor Mobile ECG device as Kardia Mobile and unveiled a second, upcoming hardware product, an Apple Watch strap that can take electrocardiogram (ECG or EKG) readings, called KardiaBand. The strap is not yet commercially available because it still needs to secure FDA-clearance.
AliveCor also announced new features for the Kardia Mobile...
